River BioMedics - Closer to the Heart
River BioMedics develops 3D human heart models based on stem cell technology that are able to mimic the pumping function of the human heart. We have validated our models with a set of drugs known to affect the heart, and aim to sell the use of these models to pharmaceutical companies for them to develop their new drugs in exchange for upfront and milestone payments. We envision to revolutionize drug discovery!
Together with Marcelo Ribeiro (CEO/CSO) and Robert Passier (scientific advisor), Lisanne is co-founder of River BioMedics. She is currently working as a business developer for the start-up company. Lisanne did her PhD research in Leiden at the department of Medicine division of Endocrinology of the Leiden University Medical Center (LUMC), where she studied genetic determinants of cardiovascular disease. Currently, she is holding a Postdoc position at this department. Her background is in Medicine (BSc, LUMC), and at the moment she is finishing the last year of her Master’s degree in Biomedical Engineering at Delft University of Technology.
Reboocon has won the AXON Innovation for Health Award 2019 for the best start-up pitch at the sixth edition of Innovation for Health and the third edition of Global Investor Forum in WTC Rotterdam on 14 February 2019. Reboocon competed against River Biomedics in the plenary afternoon programme and at the end received the majority vote from the audience as the best start-up.
Read press release
The aftermovie of Innovation for Health 2019 is online now, including highlights of the programme and exhibition.
Watch the aftermovie and experience Innovation for Health 2019 in only 2 minutes!
Looking forward welcoming you to the next edition of Innovation for Health in 2020! (date will be announced soon)
Watch the aftermovie
Did you enjoy Innovation for Health & Global Investor Forum 2019?
Take a look at our photo impression and you will experience the event of 14 February all over again!
Go to Photo Impression
© 2019 Innovation for Health